2332
HETEROCYCLES, Vol. 68, No. 11, 2006
NMR (400 MHz, CDCl
3
): δ 7.48 (1H, d, J = 7.2), 7.43 (1H, t, J = 7.6), 7.16 (1H, t, J = 7.2), 6.98 (1H, d, J
=
=
7.6), 4.53 (1H, s), 3.85 (2H, m), 3.33 (1H, d, J = 17.2), 3.0 (1H, d, J = 17.2), 2.27 (3H, s), 1.39 (3H, t, J
1
3
7.2); C NMR (100 MHz, CDCl ): δ 207.2, 175.8, 142.7, 129.9, 129.8, 123.9, 122.9, 108.7, 74.0, 49.0,
3
+
+
3
4.8, 31.2, 12.3; EI-MS: m/z 233 (M ); HR-ESI-MS: m/z 256.0948 (calcd for C13
-Allyl-3-(2-oxopropyl)-3-hydroxyindol-2-one. IR (Nujol): ν = 3317, 1716, 1699, 1621 cm ; H NMR
): δ 7.37 (1H, d, J = 7.6), 7.29 (1H, t, J = 7.6), 7.06 (1H, d, J = 7.6), 6.84 (1H, t, J =
.6), 5.88 (1H, m), 5.34 (1H, s), 5.26 (1H, m), 4.39 (1H, dd, J = 16.4, 5.2), 4.26(1H, dd, J = 16.4, 5.2),
3
H15NNaO 256.0950)
-1 1
1
(400 MHz, CDCl
3
7
3
1
1
3
.23 (1H, d, J = 17.2), 3.01 (1H, d, J = 17.2), 2.17 (3H, s); C NMR (100 MHz, CDCl
3
): δ 207.2, 175.9,
+
42.8, 130.9, 129.9, 129.6, 123.8, 123.1, 109.5, 74.0, 48.9, 42.4, 31.3; EI-MS: m/z 245 (M );
+
HR-ESI-MS: m/z 268.0941 (calcd for C14
H
15NNaO
3
268.0950)
-
1 1
1
-Butyl-3-(2-oxopropyl)-3-hydroxyindol-2-one. IR (Nujol): ν = 3354, 1712, 1688, 1616 cm ; H NMR
400 MHz, CDCl ): δ 7.36 (1H, d, J = 7.2), 7.31 (1H, t, J = 7.6), 7.05 (1H, t, J = 7.6), 6.85 (1H, d, J =
.6), 4.41 (1H, s), 3.64 (2H, m), 3.19 (1H, d, J = 16.8), 2.95 (1H, d, J = 16.8), 2.17 (3H, s), 1.68 (2H, m),
(
3
7
1
1
2
1
1
3
.34 (2H, m), 0.94 (3H, t, J = 7.6); C NMR (100 MHz, CDCl
3
): δ 207.4, 176.0, 142.9, 129.9, 129.8,
+
23.9, 122.8, 108.8, 74.1, 48.8, 40.1, 31.4, 28.9, 26.8, 22.3; EI-MS: m/z 261 (M ); HR-ESI-MS: m/z
+
84.1260 (calcd for C15
H
19NNaO
3
284.1263)
-1
1
-Hexyl-3-hydroxy-3-(2-oxopropyl)indolin-2-one. IR (Nujol): ν = 3361, 1712, 1688, 1614 cm ; H
NMR (400 MHz, CDCl ): δ 7.37 (1H, d, J = 7.2), 7.32 (1H, t, J = 7.6), 7.06 (1H, t, J = 7.6), 6.85 (1H, d, J
3
=
7.6), 4.28 (1H, s), 3.60 (2H, m), 3.17 (1H, d, J = 16.8), 2.93 (1H, d, J = 16.8), 2.18 (3H, s), 1.69 (2H,
1
3
m), 1.30 (4H, m), 0.88 (3H, t, J = 7.2); C NMR (100 MHz, CDCl
3
): δ 207.4, 176.0, 142.9, 129.9, 129.8,
+
1
3
1
23.9, 122.8, 108.8, 74.1, 48.8, 40.1, 31.4, 28.9, 26.8, 22.3; EI-MS: m/z 289 (M ); HR-ESI-MS: m/z
+
12.1571 (calcd for C17
3
H23NNaO 312.1576)
-1
1
-Benzyl-3-(2-oxopropyl)-3-hydroxyindol-2-one. IR (Nujol): ν = 3317, 1716, 1699, 1620 cm ; H
NMR (400 MHz, CDCl ): δ 7.33- 7.38 (6H, m), 7.18 (1H, d, J = 7.6), 7.04 (1H, t, J = 7.6), 6.70 (1H, t, J
3
=
7.6), 4.96 (1H, d, J = 16.4), 4.85(1H, d, J = 16.4), 4.44(1H, s), 3.27 (1H, d, J = 16.8), 3.05 (1H, d, J =
1
3
1
1
6.8), 2.19 (3H, s); C NMR (100 MHz, CDCl
3
): δ 207.3, 176.3, 142.7, 135.3, 129.9, 129.7, 128.8, 127.6,
+
27.2, 123.8, 123.1, 109.7, 74.1, 48.8, 43.8, 31.3; EI-MS: m/z 295 (M ); HR-ESI-MS: m/z 318.1112
+
(
calcd for C18
H
17NNaO
3
318.1106)
-1
1
1
-Acetyl-3-(2-oxopropyl)-3-hydroxyindol-2-one. IR (Nujol): ν = 3431, 1715, 1623, 1574 cm ; H
): δ 8.19 (1H, d, J = 7.6), 7.34 (3H, m), 7.18 (1H, d, J = 7.6), 3.36 (1H, d, J =
NMR (400 MHz, CDCl
3
1
3
1
1
7.6), 3.33 (1H, d, J = 17.6), 2.64 (3H, s), 2.04 (3H, s); C NMR (100 MHz, CDCl ): δ 205.7, 178.0,
3
+
71.1, 140.5, 130.1, 129.0, 125.3, 122.8, 116.8, 72.9, 51.1, 30.3, 26.3; EI-MS: m/z 247 (M );
+
HR-ESI-MS: m/z 270.0739 (calcd for C13
H
13NNaO
4
270.0742)